Showcase for Biotechnology 2005 Schedule
|
SUNDAY, August 14, 2005 |
|
8:00 – 8:45 AM |
Registration for 5th Annual Healthstyles 5K Race |
9:00 AM |
Start of 5k Race |
9:30 AM |
Start of 1.5 Mile Fun Walk |
1:00-8:00 PM |
Registration and Booth Setup |
6:00-7:00 AM |
Breakfast/Registration and Booth Setup | ||
7:00-8:00 AM |
Exhibit Hall Tour by Congressman John P. Murtha, U.S. Congress |
||
8:00-9:00 AM |
Opening Ceremonies | ||
| Opening Remarks: David Klementik, Chairman of the Board, Windber Research Institute |
|||
| Partner Presentations/Introductions: Michael Liebman, Ph.D., Executive Director, Windber Research Institute | |||
| Special Address: Rep. John P. Murtha, U.S. Congress |
|||
| Remarks: F. Nicholas Jacobs, President & CEO Windber Research Institute and Windber Medical Center | |||
| Closing Remarks: David Klementik, Chair of the Board, Windber Research Institute | |||
9:00-9:20 AM |
Break | ||
9:20 AM -12:00 PM |
Plenary Session 1: Integrative Health and Health Policy |
||
9:20-9:50 AM |
Lecture 1: (Keynote) Individualized Genomic Stress Induction Signature Reversal With Recreational Music-Making Barry Bittman, MD |
||
9:50-10:05 AM |
Lecture 2:Identification of Molecular Changes Associated with Breast Tumor Phenotype in African American Women Lori Field, Ph.D. |
||
10:05-10:35 AM |
Lecture 3: Using Mixed Methodologies to Study Health-Related Beliefs, Practices, and Outcomes Etienne J. (Tina) Phipps, Ph.D. |
||
10:35-10:50 AM |
Lecture 4: OPEN |
||
10:50-11:20 AM |
Lecture 5: Dealing With Uncertainty in the Assessment of Diagnostic and Prognostic Factors in Cancer |
||
11:20-11:50 AM |
Lecture 6: Biomedical Informatics Research at Windber Research Institute |
||
12:00-1:00 PM |
Lunch (windber High School) Introduction by Joan Schank, Director of Education, PTEI |
||
1:00-5:20 PM |
Plenary Session 2: Genomics |
Plenary Session 3: CME |
|
1:00-2:00 PM |
Lecture 7 (Keynote): The Future Direction of the Human Genome Project |
1:30-2:00 PM |
(Keynote) CME - Cardiovascular: Cardiac CT: A new method to assess coronary artery disease Thomas J. Brady, M.D. |
2:00-2:30 PM |
Lecture 8: When Good Data Goes Bad: Thoughts Regarding Data Quality [Abstract] Roger E. Davis, Ph.D. |
2:00-2:30 PM |
CME – Cardiovascular: Cardiac PET-CT Imaging Joseph Machac, M.D. |
2:30-3:00 PM |
Lecture 9: HER2 Gene Amplification as a Marker for Global Genomic Instability |
2:30-3:00 PM |
CME – Cardiovascular: Changing Medical Management with FDG PET Robert S. Bridwell, M.D., MBA |
3:00-3:20 PM |
Break | 3:00-3:20 PM |
CME – Cardiovascular: PET/CT State of the Art: Clinical Applications Ajit N. Shah, M.D., MBA |
3:20-3:50PM |
Lecture 10: Novel Ion Channel Genes: From Fertility to Respiratory Rhythm Control |
3:30-4:30 PM |
CME – PET/CT: PET Imaging Technology and Applications in Cardiology Phil Vernon |
3:50-4:20 PM |
Lecture 11: Subject TBD |
||
4:20-4:50 PM |
Lecture 12: An Application of Array CGH Technology to Genomic Studies Norma J. Nowak, Ph.D. |
||
4:50-5:20 PM |
Lecture 13:
The Role of Boron in Prostate Cancer Stephen Carper, Ph.D. |
||
6:00-9:00 PM |
VIP Reception Joan Schank, MPA - Pittsburgh Tissue Engineering Initiative (PTEI) |
||
7:00-7:50 AM |
Onsite Registration/Breakfast | ||
7:50-8:00 AM |
Introduction Michael N. Liebman, Ph.D. Chief Scientific Officer, Windber Research Institute |
||
8:00 AM -12:00 PM |
Plenary Session 4: Modeling |
||
8:00-8:30 AM |
Lecture 14 (Keynote): Stochastic Simulation of Biochemical Systems William H. Sanders, Ph.D. |
||
8:30-9:00 AM |
Lecture 15: The NIH Molecular Libraries Initiative and the PubChem Database Stephen Bryant, Ph.D. |
||
9:00-9:30 AM |
Lecture 16: Use of Bayesian Networks and Machine Learning to Map Complex Diagnoses to Outcomes John Eberhardt, Ph.D. |
||
9:30-10:30 AM |
Lecture 17: Bayesian and Non-Bayesian Computational Analyses of Heterogeneity in Breast Disease: A Case Study in Datamining Clinical Records for Disease Hypothesis Generation |
||
10:00-10:20 AM |
Break | Plenary Session 5: CME |
|
10:20-10:50 AM |
Lecture 18: Breast Cancer Risk Models – Integrating Molecular, Imaging, and Patient Diagnostics to Improve Disease Management Christopher Hammond |
10:00 AM-12:00 PM | (Keynote) CME- Mammography 1.) Digital Mammography – Current Capabilities and Limitations 2.) Medicolegal Aspects of Breast Cancer – Challenges for the Whole Breast Physician Team Jay Parikh, M.D. FRCP |
10:50-11:20 AM |
Lecture 19: Towards Mechanistic Modeling and Systematic Analysis of Human Cells for Cancer Prognosis and Treatment [Abstract] Wen-mei Hwu, Ph.D. |
||
11:30 AM-12:00 PM |
Lecture 20: The Role of Diagnostic Testing in the Treatment of Colorectal Cancer |
||
12:00-1:00 PM |
Lunch | ||
1:00-4:00 PM |
Plenary Session 6: Proteomics |
Plenary Session: CME | |
1:00-1:30 PM |
Lecture 21 (Keynote): New Multi-Dimensional Strategies for Identifying Low Abundance Proteins in Serum and Plasma for Disease Biomarker Discovery David Speicher, Ph.D. |
1:00-2:00 PM |
CME – Breast Imaging and Ultrasound Applications Daniel A. Tyskiewicz RDMS |
1:30-2:00 PM |
Lecture 22: Chromatography of Difficult and Water-Insoluble Proteins Andrew J. Alpert, Ph.D. |
2:00-2:30 PM |
|
2:00-2:30 PM |
Lecture 23: Genetic Analysis of Complex Disease: The SOP3 Web Server for Design of Oligonucleotide Primer Trios Steven Ringuist |
2:30-3:00 PM |
|
2:30-3:00 PM |
Lecture 24: Proteomic Poetry: A Pattern-based Approach to Biomarker Discovery Wade T. Rogers, Ph.D. |
3:00-3:20 PM |
|
3:00-3:30PM |
Lecture 25: Perifosine, a Novel Alkylphospholipid as an Inhibitor of cPLA2 for Human Cancers Krishnendu K. Roy, Ph.D. |
3:30-4:30 PM |
|
3:30-4:00 PM |
Lecture 26: Applying a "Divide and Conquer" Strategy to Proteomic Discovery: IgY Proteom/Partitioning and ProteomeLab PF 2D/Fractionation Applications in Biomarker Discovery Bob Stetler |
||
4:00-4:15 PM |
Closing Ceremonies | ||